Revolutionary cancer treatment: 9 out of 10 patients with leukaemia were cured
A revolutionary treatment of cancer that could stop the disease from ever coming back will soon become widely available, scientists said yesterday.
According to Sky News, US scientists developed a new cancer drug which offers hope of a lasting cure.
More than nine out of ten participants with a severe form of leukaemia saw their symptoms completely vanish.
Four out of five patients with some other blood cancers responded positively to the treatment and more than half ended up symptom free.
The technique involves the removal of immune cells called T-cells from patients and tagging them with “receptor” molecules that target cancer. Then, they are put back into the patient in an infusion.
The targeting molecules, known as chimeric antigen receptors or Cars, came from specially bred genetically engineered mice.
Once attached to the T-cells, they reduce the ability of the cancer to shield itself from the body’s natural immune system.
Lead scientist Professor Stanley Riddell, from the Fred Hutchinson Cancer Research Center in Seattle, US, said the results were among patients who were projected to have two to five months to live.
“This is extraordinary. This is unprecedented in medicine to be honest, to get response rates in this range in these very advanced patients.” he said.
You may be interested
All coronavirus vaccines in Greece available to citizens aged 40-44 as of Friday, says health expertPanos - May 18, 2021
Citizens aged 40-44 will be able to book vaccination appointments for any of the coronavirus vaccines currently available in Greece…
Dendias will be the first EU FM to visit Israel and Palestine since the start of the crisisPanos - May 18, 2021
Greece as pillar of stability and champion of promoting security and prosperity in the wider region is actively involved in…
Erdogan: “84 million Turks will continue to defend Jerusalem” (video)makis - May 17, 2021
Turkish President Recep Erdogan unleashed an unprecedented attack on US President Joe Biden on the occasion of the approval given…